<DOC>
	<DOC>NCT00518934</DOC>
	<brief_summary>The purpose of this study is to analyze the safety and efficiency of therapeutic angiogenesis for patients with limb ischemia by transplantation of human cord blood mononuclear cells.</brief_summary>
	<brief_title>Study for Safety and Efficiency of Therapeutic Angiogenesis for Patients With Limb Ischemia by Transplantation of Human Cord Blood Mononuclear Cell</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<criteria>Patients with ischemic symptoms such as claudication, rest pain or nonhealing ischemic wound Without evidence of improvement in response to conventional medical therapy Not candidates for surgical intervention or radiologic intervention Malignant disease More than 60 years old Other significant medical conditions, including diabetes mellitus, hypertension, hyperlipidemia, etc.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>Safety and efficiency of angiogenesis for patients with limb</keyword>
	<keyword>ischemia by transplantation of human cord blood mononuclear</keyword>
	<keyword>cells</keyword>
</DOC>